Risk factors

First-time filing highlights fair value uncertainty of private assets under the 1940 Act, capital deployment and market competition risks, and macroeconomic exposures including inflation and interest rates.

Growth relies heavily on rapid restaurant expansion, third-party supply chains, and digital/delivery channels.

Cerus is commercializing the INTERCEPT Blood System amid concentration risks and stringent global healthcare regulations. The company relies heavily on third-party manufacturers, government contracts like BARDA, and achieving broader market adoption. Sustaining profitability and financing ongoing clinical developments remain central financial challenges.

Certara faces primary risks related to customer R&D spending reductions, biopharmaceutical industry consolidation, and regulatory acceptance of biosimulation products.

Regional banking operations dominate, with geographical concentration in West Virginia, Kentucky, Virginia, and southeastern Ohio.

Chatham Lodging Trust faces heavy concentration risks tied to its external manager IHM and franchisors. Lodging cyclicality, debt financing costs, and capital expenditure needs dominate risks.

ClearPoint Neuro faces high customer concentration, with one pharmaceutical partner accounting for 9 percent of total revenues and 17 percent of clinical service revenues in 2024. Operations depend on a single manufacturing facility in Carlsbad, California, exposing the company to fire and earthquake risks. The cumulative net loss reached 191.4 million dollars by the end of 2024.

CNO Financial Group faces extensive state insurance and healthcare regulatory compliance risks that could impact business flexibility.

Central Pacific Financial Corp is heavily concentrated in the Hawaii market, tying its performance to tourism, real estate, and regional economic conditions. Rising interest rates, credit losses, and commercial real estate exposure significantly impact net interest margins and asset quality. The bank faces intense competition and growing compliance demands from new initiatives like Banking-as-a-Service.

The company faces significant regulatory, environmental, and operational risks across its natural gas, electric, and propane distribution services.

Oil, natural gas, and NGL price volatility heavily impacts revenues, capital expenditures, and financial commitments.

CRH relies heavily on cyclical construction markets and public infrastructure spending for its building materials business. The company faces significant financial exposure from $14.3 billion in gross debt, mining permit needs, and operational risks from commodity pricing and fixed costs.